Sinovac Biotech (Sinovac Biotech) Days Sales Outstanding

: 599.39 (As of Jun. 2023)

View and export this data going back to 2003. Start your Free Trial

Sinovac Biotech's average Accounts Receivable for the six months ended in Jun. 2023 was $461.1 Mil. Sinovac Biotech's Revenue for the six months ended in Jun. 2023 was $140.4 Mil. Hence, Sinovac Biotech's Days Sales Outstanding for the six months ended in Jun. 2023 was 599.39.

The historical rank and industry rank for Sinovac Biotech's Days Sales Outstanding or its related term are showing as below:

SVA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.06 Med: 137.27 Max: 546.89
Current: 546.89

During the past 13 years, Sinovac Biotech's highest Days Sales Outstanding was 546.89. The lowest was 11.06. And the median was 137.27.

SVA's Days Sales Outstanding is not ranked
in the Biotechnology industry.
Industry Median: 72.335 vs SVA: 546.89

Sinovac Biotech's Days Sales Outstanding increased from Jun. 2022 (142.51) to Jun. 2023 (599.39).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Sinovac Biotech Days Sales Outstanding Historical Data

The historical data trend for Sinovac Biotech's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinovac Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

109.38

137.26

129.64

11.06

173.70

Sinovac Biotech Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															13.66	25.19	142.51	477.14	599.39

Competitive Comparison

For the Biotechnology subindustry, Sinovac Biotech's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinovac Biotech Days Sales Outstanding Distribution

For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sinovac Biotech's Days Sales Outstanding falls into.

Sinovac Biotech Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sinovac Biotech's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (923.798	+	497.014)	/	2 )	/	1492.761	*	365
=	710.406					/	1492.761	*	365
=	173.70

Sinovac Biotech's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (497.014	+	425.245)	/	2 )	/	140.404	*	365 / 2
=	461.1295					/	140.404	*	365 / 2
=	599.39

Sinovac Biotech (NAS:SVA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Sinovac Biotech Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sinovac Biotech's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinovac Biotech (Sinovac Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinovac Biotech Ltd (NAS:SVA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.39, Shangdi Xi Road, Haidan District, Beijing, CHN, 100085

Website

http://www.sinovac.com

Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.

Executives

Lily Wang	director, 10 percent owner, officer: Chief Financial Officer	300 MURCHISON DR., MILLBRAE CA 94030
Ifg Investments Services Inc	10 percent owner	PO BOX 822, CHARLESTOWN FEDERATION OF ST KITTS & NEVIS WEST INDIES P8 00000
Yin Weidong	director, 10 percent owner, officer: President and CEO
Terry G Bowering	director, 10 percent owner, officer: President, CEO	10 CEDAR MEADOW DRIVE REGINA A9 S4X 3J6